This study is currently not recruiting participants.

A Phase 2 Randomized Placebo Controlled Double Blind Proof-of-Concept Study of the Efficacy and Safety of PF-02545920 in Subjects with Huntington's Disease

Study on Investigational Medication for Huntington's Disease

Not Recruiting
30 years - 65 years
All
Phase N/A

Brief description of study.

The purpose of this study is to compare the safety, tolerability and effectiveness of two doses of PF-02545920 to placebo on improving voluntary movement and overall symptoms in subjects with Huntington's disease.

Detailed description of study

The purpose of this study is to assess the efficacy pf 26-week oral daily dosing with PF-02545920 on motor function in subjects with Huntington's disease.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Huntington's disease
  • Age: 30 years - 65 years
  • Gender: All

The purpose of this study is to assess the safety, tolerability, and effectiveness of an investigational medication compared to a placebo in improving voluntary movement and overall symptoms in people with Huntington's disease. Huntington's disease is a condition that affects the brain and causes problems with movement, thinking, and behavior.

Participants will receive either one of two doses of the investigational medication or a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine. The study involves taking the medication orally every day for 26 weeks to evaluate its effect on motor function.

  • Who can participate: Individuals aged 18 to 65 years diagnosed with Huntington's disease may be eligible. Key eligibility factors include specific clinical criteria related to the progression and symptoms of the disease.
  • Study details: Participants will receive either one of two doses of the investigational medication or a placebo. The placebo is an inactive substance that looks like the investigational medicine but does not contain any medicine.
Updated on 19 Feb 2024. Study ID: 1408743900

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team